Cortexyme Financial Statements ()
|
|
|
|
Report date
|
|
|
31.12.2017 |
31.12.2018 |
16.03.2020 |
01.03.2021 |
01.03.2022 |
|
09.08.2022 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Operating Income, bln rub |
|
|
-10.4 |
-12.1 |
-39.2 |
-78.9 |
-89.9 |
|
-149.4 |
|
EBITDA, bln rub |
? |
|
-10.5 |
-11.5 |
-39.2 |
-78.9 |
-90.3 |
|
-83.5 |
|
Net profit, bln rub |
? |
|
-12.2 |
-12.5 |
-37.0 |
-76.8 |
-89.9 |
|
-149.9 |
|
|
OCF, bln rub |
? |
|
-9.83 |
-11.7 |
-33.3 |
-50.8 |
-62.9 |
|
-47.9 |
|
CAPEX, bln rub |
? |
|
0.077 |
0.212 |
0.055 |
0.052 |
0.180 |
|
0.049 |
|
FCF, bln rub |
? |
|
-9.90 |
-11.9 |
-33.3 |
-50.9 |
-63.1 |
|
-47.9 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
|
|
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
10.4 |
12.1 |
39.2 |
78.9 |
90.3 |
|
150.1 |
|
Cost of production, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
R&D, bln rub |
|
|
9.10 |
10.1 |
30.2 |
61.3 |
60.8 |
|
94.8 |
|
Interest expenses, bln rub |
|
|
1.64 |
0.957 |
0.000 |
0.000 |
0.000 |
|
0.662 |
|
|
Assets, bln rub |
|
|
7.72 |
72.9 |
124.4 |
189.5 |
133.2 |
|
117.9 |
|
Net Assets, bln rub |
? |
|
-20.3 |
71.4 |
115.5 |
172.3 |
118.6 |
|
111.5 |
|
Debt, bln rub |
|
|
7.17 |
0.000 |
0.000 |
0.208 |
0.420 |
|
0.133 |
|
Cash, bln rub |
|
|
7.34 |
71.7 |
99.9 |
133.8 |
106.8 |
|
94.7 |
|
Net debt, bln rub |
|
|
-0.17 |
-71.7 |
-99.9 |
-133.6 |
-106.4 |
|
-94.5 |
|
|
Ordinary share price, rub |
|
|
|
|
56.1 |
27.8 |
12.6 |
|
2.22 |
|
Number of ordinary shares, mln |
|
|
21.6 |
21.6 |
19.1 |
29.2 |
29.8 |
|
32 467 |
|
|
Market cap, bln rub |
|
|
0 |
0 |
1 070 |
811 |
376 |
|
72 077 |
|
EV, bln rub |
? |
|
0 |
-72 |
970 |
677 |
269 |
|
71 982 |
|
Book value, bln rub |
|
|
-20 |
71 |
115 |
172 |
119 |
|
105 |
|
|
EPS, rub |
? |
|
-0.57 |
-0.58 |
-1.94 |
-2.63 |
-3.02 |
|
0.00 |
|
FCF/share, rub |
|
|
-0.46 |
-0.55 |
-1.75 |
-1.74 |
-2.12 |
|
0.00 |
|
BV/share, rub |
|
|
-0.94 |
3.31 |
6.06 |
5.90 |
3.98 |
|
0.00 |
|
|
FCF yield, % |
? |
|
|
|
-3.11% |
-6.28% |
-16.8% |
|
-0.07% |
|
ROE, % |
? |
|
60.3% |
-17.5% |
-32.0% |
-44.6% |
-75.8% |
|
-134.4% |
|
ROA, % |
? |
|
-158.5% |
-17.1% |
-29.7% |
-40.6% |
-67.5% |
|
-127.2% |
|
|
P/E |
? |
|
0.00 |
0.00 |
-28.9 |
-10.5 |
-4.18 |
|
-480.7 |
|
P/FCF |
|
|
0.00 |
0.00 |
-32.1 |
-15.9 |
-5.95 |
|
-1 505 |
|
P/BV |
? |
|
0.00 |
0.00 |
9.27 |
4.71 |
3.17 |
|
687.7 |
|
EV/EBITDA |
? |
|
0.02 |
6.25 |
-24.8 |
-8.58 |
-2.98 |
|
-861.6 |
|
Debt/EBITDA |
|
|
0.02 |
6.25 |
2.55 |
1.69 |
1.18 |
|
1.13 |
|
|
R&D/CAPEX, % |
|
|
11 817% |
4 757% |
54 935% |
117 898% |
33 775% |
|
193 447% |
|
| Cortexyme shareholders |
